Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouse.
Ayres
E A
EA
Department of Pharmacology, University of Arizona, Tucson 85724.
Parkhurst
D N
DN
Fang
S
S
Kramer
T H
TH
Hruby
V J
VJ
Burks
T F
TF
D000595:Amino Acid Sequence; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D020109:Devazepide; D005746:Gastric Emptying / Q000187:drug effects; D005772:Gastrointestinal Transit / Q000187:drug effects*; D007211:Indoles / Q000494:pharmacology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D008969:Molecular Sequence Data; D009019:Morphinans / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000031:analogs & derivatives*; D009292:Narcotic Antagonists / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology; D010671:Phenylurea Compounds; D011930:Reaction Time / Q000187:drug effects; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012844:Sincalide / Q000031:analogs & derivatives* / Q000494:pharmacology
D000700:Analgesics; D001570:Benzodiazepinones; D007211:Indoles; D009019:Morphinans; D009292:Narcotic Antagonists; D010446:Peptide Fragments; D010455:Peptides; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin; C066684:SNF 8702; C072950:SNF 8906; D009270:Naloxone; C058121:L 365260; D009271:Naltrexone; C009862:connective tissue-activating peptide; D002766:Cholecystokinin; C055382:naltrindole; D020109:Devazepide; D012844:Sincalide